期刊文献+

32种抗菌药物对临床分离猪源链球菌的体外抗菌活性 被引量:13

Antimicrobial Susceptibility in vitro of 32 Drugs Against Pig Streptococcus Isolates in China
下载PDF
导出
摘要 采用微量稀释法测定了 32种药物对临床分离猪源链球菌的体外最小抑菌浓度 (MIC) ,以美国临床检验标准委员会 (NCCLS)的临界浓度做为判断标准 ,判定了猪源链球菌对 32种药物的耐药性。结果表明 ,临床分离的菌株以耐药菌为主 ,且 96 6 %的菌株呈多重耐药 ,4 1%菌株为链霉素高耐药菌株 (MIC≥ 2mg mL) ;对磺胺类药物(92 3%~ 98 3% )、氨基糖甙类药物 (70 8%~ 78 5 % )、四环素类 (72 3% )、林可胺类 (6 6 2 %~ 6 4 6 % )、大环内酯类(5 3 8%~ 6 7 7% )耐药性最为严重 ,对青霉素类 (18 5 %~ 5 3 8% )、头孢菌素类 (18 5 %~ 5 6 9% )、泰妙灵 (2 1 5 % )和喹诺酮类药物 (36 9%~ 78 5 % )耐药性次之 ,而所选菌株对氯霉素类药物氟苯尼考均敏感 ;检测了所有耐 β内酰胺类抗生素菌株是否产 β内酰胺酶 。 A number of 65 Streptococcus species isolated from diseased pigs were surveyed for in vitro minimal inhibitory concentration (MIC) to 32 drugs by microdilution test. Clinical categorization of isolates as susceptible or resistant was based on MIC interpretative standards of the National Committee for Clinical Laboratory Standards(NCCLS). None of the strains were susceptible to all antimicrobial compounds tested and most strains(96.6%) were multidrug-resistant. High level resistance to streptomycin was also detected. Resistance to sulfonamides(92.3%~98.3%), aminoglycosides (70.8%~78.5%), lincosamides (66.2%~64.6%), tetracyclines (72.3%) and macrolides(53.8%~67.7%) were most frequent, then β-lactam(18.5%~56.9%) and quinolones(36.9%~78.5%) resistance, while all strains were susceptible to florfenicol,78.5% strains were susceptible to Taimulin. All resistant strains to β-lactam were tested for β-lactamase production and the results were negative.
出处 《微生物学报》 CAS CSCD 北大核心 2004年第6期794-799,共6页 Acta Microbiologica Sinica
基金 国家"973项目"(G19990 1190 6)~~
关键词 微量稀释法 猪源链球菌 体外最小抑菌浓度 耐药性 Microdilution test, Pig Streptococcus isolates, in vitro MIC, Drug resistance Foundation item: Key Project of Chinese National Programs for Foundamental Research and Development(G1999011906)
  • 相关文献

参考文献9

  • 1Clifton-Hadley F A. Streptociccus suis type 2 infection. British Veterinary Journary, 1983,139:1-5.
  • 2Arends T P, Zanen H C. Meningitis caused by Streptococcus suis in human. Research Infection Dis, 1988,10:131-137.
  • 3Aarestrup F M, Rasmussen S R, Artursson K.Trends in the resitance to antimicrobial agents of Streptococcus suis isolates from Denmark and Sweden. Veterinary Microbiology,1998,63:71-80.
  • 4Martel A,Baele M, Deviese L A. Prevalence and mechanism of resistance against macrolides and lincosamides in Streptococcus suis isolates. Veterinary Microbiology, 2001,83:287-297.
  • 5Yasushi K, Takaharu Y. A 10-year survey of antimicrobiol susceptibility of Streptococcus suis isolates from Swine in Japan.Veterinary Medicine Science,2000,62:1053-1057.
  • 6National Committee for Clinical Laboratory Standards,1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals approved standard. NCCLS Document M31-A(ISBN1-56238-377-9).NCCLS, 940 West Valley
  • 7Jones M E, Peters E, Weersink A, et al. Widespread occurance of integrons causing mutipie resistance in bacteria. Lancet,1997,349:1742-1743.
  • 8Peters E D J, Hall M A L, Box A T A, et al. Novel gene cassettes and integrons.Antimicrob Agents Chemother, 2001,45:2961-2963.
  • 9Courvalin P. Transfer of antibiotic resistance genes between gram-positive and gram-negative bacteria. Antimicrob Agents Chemother, 1994,38:1447-1451.

同被引文献137

引证文献13

二级引证文献138

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部